
FDA Draft Guidance on Third Party Review Program: FDA Expectations
The article addresses the aspects related to the authority’s expectations associated with the respective program.
The article addresses the aspects related to the authority’s expectations associated with the respective program.
The new article highlights the aspects related to the classification rules applicable to specific categories of healthcare products.
The new article highlights the aspects related to the review process itself.
The article highlights the key points related to the specific aspects to be considered when using real-world data to support marketing applications related to medical devices.
The new article highlights the aspects related to the costs associated with establishment licenses, and supporting documentation interested parties should submit, and also explains cooperation between different regulating authorities and bodies.
The new article highlights the key points related to the studies to be carried out to demonstrate a positive supply effect.